The basis for these conclusions is data from about 80 clinical and epidemiological studies. Copperhomocysteine complexes and possible role in cardiovascular disease. Homocysteine has been evaluated as a potential marker of cardiovascular disease cvd in the general population and as a potential risk marker among people with cvd. There is an association between serum homocysteine concentration and cardiovascular disease, but it is not known whether the association is causal. Our report was careful to state that it remained to be seen whether lowering homocysteine would reduce the risk of cardiovascular disease. Design cross sectional study of the general population. Homocysteine as a risk factor for cardiovascular disease in patients treated by dialysis. An elevated plasma level of homocysteine has long been known as an independent predictor of cardiovascular disease. Homocysteine, vitamins, and cardiovascular disease aha journals. Our main findings were subsequently tested in tens of thousands of vascular disease cases and controls in many diverse settings and populations 1,4. Homocysteine has become a target for many basic and clinical investigators because of a clinical syndrome described almost 40 years ago. Measurement of total plasma homocysteine is the sum of. The association between homocysteinelowering interventions and risk of.
Cvd is among the diseases with multiple contributing factors, hence. Homocysteine was one of the nontraditional risk factors considered in the recommendation. Although about half of americans have levels of cholesterol that place them at high risk of coronary artery disease, hypercholesterolemia is now considered only one risk factor within a complex amalgam of factors. The emergence of new risk factors for heart disease and other major human illnesses are often greeted with skepticism in the scientific community. Homocysteine is an amino acid that has been evaluated as a potential marker of cardiovascular disease cvd and increased risk of thrombosis in the general population and as a potential risk marker for people with cvd and thrombotic disorders. A metaanalysis judith heinz, msc, 1siegfried kropf, phd,2 claus luley, md, and jutta dierkes, phd background. Homocysteine in health and disease annals of internal. When death due to cardiovascular disease which occurred in 50 patients was used as the end point in the analysis, the relation between homocysteine levels and mortality was slightly strengthened. Homocysteine and reclassification of cardiovascular. Homocysteine and cardiovascular disease circulation research. The correlation of homocysteine with prevalent cardiovascular disease has. Data sources medline was searched for articles published. Homocysteine as a risk factor for cardiovascular disease. Furthermore, studies of primary and secondary prevention show no evidence that taking folic acid or other b vitamins lowers the risk of cardiovascular events.
Mthfr gene polymorphism, homocysteine and cardiovascular. Homocysteine, folate, vitamin b12, and cardiovascular risk. Homocysteine and cardiovascular disease slideshare. Information has been emerging regarding a connection between homocysteine metabolism and cognitive function, from mild. Homocysteine testing in the screening, diagnosis, and management of cardiovascular disease and venous thromboembolic disease. In the hope2 trial of highrisk patients, treatment with folic acid, vi. As a free amino acid, it exists in either the reduced homocysteine, a thiol or oxidized. Homocysteine, vitamins, and cardiovascular disease. Such patients have moderately elevated plasma homocysteine and greatly increased cardiovascular risk that is largely unex plained. What is already known on this topic there is an association between serum homocysteine concentration and cardiovascular disease, but it is not known whether the association is causal. In fact, a high level of homocysteine is a risk factor for heart disease. Homocysteine, folate, and cardiovascular disease request pdf. In the general population, increased homocysteine concentrations are a risk factor for cardiovascular disease and mortality. Homocysteine, b vitamins, and risk of cardiovascular disease.
The realization that homocysteine is a risk factor for vascular disease coincided with observations initially made by lindenbaum et al 8 that homocysteine along with methylmalonic acid was a sensitive indicator of subtle vitamin b 12 deficiency in patients presenting with dementia, psychosis, ataxia, or neuropathy. Homocysteine is an amino acid produced by the body and also is in your blood. Elevated plasma homocysteine hcy concentration is considered a. Its associated with low levels of vitamins b6, b12, and folate, as well as renal disease. Cardiovascular disease cvd1 is the leading cause of mortality in the united states and in most western countries. Homocysteine hcy is an amino acid formed by demethylation of methionine. Mthfr gene polymorphism, homocysteine and cardiovascular disease claudio cortese1 and corradino motti2 1department of internal medicine, university of tor vergata, via di tor vergata 5, 003 rome, italy. Cardiovascular diseases cvd as the name suggests, comprise of diseases of the heart and blood vessels. When the levels get too high, it increases your risk of heart disease, heart attack, and stroke.
Clinical practice guidelines cardiovascular disease in ckd. Objective to assess the relationship of homocysteine concentrations with vascular disease risk. Subsequent ecological, crosssectional, casecontrol, nested casecontrol, and cohort studies by and large indicate an association between elevated plasma homocysteine level and cardiovascular disease 58. There were significant associations between homocysteine and the three diseases. Homocysteine testing may be ordered as part of assessing a persons risk of cardiovascular disease, depending on the individuals age and other risk factors. In epidemiologic studies, the plasma total homocysteine level has been found to be a risk factor for cardiovascular disease. Cardiovascular disease is believed to account for one third of all deaths worldwide, and the prevalence is still on the rise. Homocysteine and cardiovascular disease aharon roberts fcsfn 648 2. Homocysteine and neurologic disease neurology jama. Since vitamins b6, b12, and folate are necessary to metabolize homocysteine, increased levels of the amino acid may be a sign of deficiency in those vitamins. Elevated circulating homocysteine levels have been found in people with cardiovascular disease. Cardiovascular disease homocysteine is a sulfurcontaining amino acid, coohchch 2ch 2shnh 3, that is formed during methionine metabolism. Sulfur containing nonessential amino acid that is not found in the diet. Homocysteine and vitamins in cardiovascular disease.
Impaired renal function, enzymatic polymorphisms, and low levels of bgroup vitamins dispose to hyperhomocysteinaemia hhcy. Copper and homocysteine in cardiovascular diseases. Elevated plasma homocysteine levels have re cently been implicated as a new risk factor for coronary artery disease. However, danesh and lewingtons metaanalysis 8 indicates that the more rigorous the epidemiologic methods, the weaker the association. The hyperhomocysteine basis of cardiovascular disease homocysteine is a sulfurcontaining amino acid, coohchch 2ch 2shnh 3, that is formed during methionine metabolism. It is a thiol compound derived from methionine and involved in two main metabolic pathways. Vitamins, homocysteine and cardiovascular risk springerlink. The basis for these conclusions is data from about 80 clinical and epidemiological studies including more than 10,000 patients. Relationship of homocysteine with cardiovascular disease and. It may also be ordered following a heart attack or stroke to help guide treatment. Studies done in the 1980s and 1990s linked elevated blood levels of homocysteine to increased risk of premature coronary artery disease, stroke.
This association may be causalit is biologically plausible, fairly strong, graded, and an increase in plasma homocysteine preceeds the onset of vascular disease. Studies are now in progress to estab lish whether such therapy will reduce cardiovascular risk. Homocysteine is an amino acid that is typically present in very small amounts in all cells of the body. Background homocysteine is a sulfurcontaining amino acid that is rapidly oxidized in plasma into homocysteine and cysteinehomocysteine disulfide. Role of homocysteine in the development of cardiovascular disease.
Their data suggest that an increase in homocysteine levels is not likely to result in an increase in risk of coronary heart disease. Homocysteine an emerging cardiovascular risk factor. Homocysteine testing in the screening, diagnosis, and management of cardiovascular disease and venous thromboembolic disease subsequently, prospective epidemiologic studies were conducted to determine if an elevated plasma level of homocysteine was an independent risk factor for cvd and could be used to improve current risk prediction models. Medical coverage policy homocysteine testing in the.
In light of the numerous observational studies that have found a positive association between plasma homocysteine levels and the risk of cardiovascular disease, the results of two. As a free amino acid, it exists in either the reduced homocysteine, a thiol or oxidized homocystine, a disulfide rssr form. Its redox chemistry is dominated by its thiol group sh, which in. Finally, common diseases associated with elevated homocysteine are discussed with the focus on cardiovascular disease and neural tube defects. However, it is not known whether this also applies to patients with endstage renal disease. Wilcken the possibility that modest elevations in the level of blood homocysteine hyperhomocysteinaemia could contribute to cardiovascular disease arose from investigation of patients with rare, severe homocysteine elevations caused by. An elevated level of total homocysteine thcy in blood, denoted hyperhomocysteinemia, is emerging as a prevalent and strong risk factor for atherosclerotic vascular disease in the coronary, cerebral, and peripheral vessels, and for arterial and venous thromboembolism. Hyperhomocysteinemia clinmed international library. Downloaded from access provided by university of western ontario on 021417. Homocysteine an emerging cardiovascular risk factor article by pamlab. Objectives the purpose of this study was to examine whether adding homocysteine hcy to a model based on traditional cardiovascular disease cvd risk factors improves risk classification. Homocysteine testing in the screening, diagnosis, and. Context it has been suggested that total blood homocysteine concentrations are associated with the risk of ischemic heart disease ihd and stroke.
Homocysteine and folate metabolism homocysteine is an amino acid not used in protein synthesis. Although links have been established between hyperhomocysteinemia and elevated risk for cardiovascular events, the precise role of plasma hcy in cardiovascular disease is unclear. Homocysteine, b vitamins, and the risk of cardiovascular. Homocysteine, a marker of cardiovascular disease risk, is. The observation that blood cu and hcy were simultaneously elevated in patients with cardiovascular disease mansoor et al. Homocysteine testing in the screening, diagnosis, and management of cardiovascular disease and venous thromboembolic disease a.
A common single gene mutation that reduces the activity of an enzyme involved in folate metabolism mthfr is associated with a moderate 20% increase in serum homocysteine. Pdf elevated homocysteine hcy levels can be caused by a number of factors, including folate and bvitamin deficiency, preexisting. Homocysteine testing in the screening, diagnosis, and management of cardiovascular disease and venous thromboembolic disease 2. Homocysteine the hidden factor and cardiovascular disease. The clinical significance of elevated plasma homocysteine.
Abstractalthough evidence suggests that the homocysteine hypothesis is still relevant as a predictor of cardiovascular risk, we cannot conclude that measuring the homocysteine level is useful in guiding treatment. The homocysteine cardiovascular disease association was slightly strengthened in women, but when the highest and the lowest quintiles of homocysteine were compared, risk of hypertension showed a threefold increase and a twofold increase in women and men respectively. Causes can be genetic homocystinuria or alcoholism. Homocysteine lowering with folic acid and b vitamins in. Moderately elevated total plasma homocysteine levels have been reported in patients with overt hypothyroidism, a condition that is associated with an increased risk for cardiovascular disease. Role of homocysteine in the development of cardiovascular. Objective to examine the hypothesis that the higher rates of coronary heart disease chd in indians south asians compared with malays and chinese is partly attributable to differences in blood concentrations of homocysteine, and related blood concentrations of folate and vitamin b12. Folate, vitamin b 6, and vitamin b 12 contribute to the conversion of homocysteine to methionine by providing methyl groups, thereby decreasing homocysteine levels, as illustrated in the figure below. While the present analysis will provide an insight into causeandeffect of hyperhomocysteinemia and cardiovascular diseases, the potential. The methioninehomocysteine cycle and its effects on. Homocysteine is an emerging new risk factor for cardiovascular disease.
A common single gene mutation that reduces the activity of an enzyme involved in folate metabolism mthfr is associated with a moderate. Background data on using hcy to reclassify individuals in various risk categories beyond traditional approaches have not been adequately scrutinized. Elevated homocysteine hcy levels can be caused by a number of factors, including folate and bvitamin deficiency, preexisting atherosclerotic disease, diabetes and various drugs. Elevated plasma homocysteine hcy concentration is considered a risk factor for cardiovascular disease and may also be associated with hypertension. The role of homocysteine as a causal risk factor for cardiovascular disease remains controversial. An extend metaanalysis suggested that an increment of homocysteine of 5 mmoll is comparable to the increase in the risk of coronary artery disease caused by cholesterol elevation of 0. Relationship of homocysteine with cardiovascular disease. A raised plasma level of the amino acid homocysteine is associated with increased risk of cardiovascular disease. Obesity is a risk factor in developing renal disease 3 and weight loss programmes can help obese predialysis patients in by reducing proteinuria, bp and rate of renal decline 4. Robert clarke and colleagues conduct a metaanalysis of unpublished datasets to examine the causal relationship between elevation of homocysteine levels in the blood and the risk of coronary heart disease. Homocysteine, b vitamins, and cardiovascular disease nejm. Homocysteine and risk of ischemic heart disease and stroke. That is because the body normally converts homocysteine into other products quickly.
170 1346 590 605 1340 512 1297 1444 1492 740 1580 1073 819 168 1000 879 1154 1045 297 383 606 1563 289 22 38 1185 681 292 1330 559 1143 321 1486 542 1057 698 813 1370 1274 595 344 1441 279 125 978